These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2885897)

  • 1. Adrenocortical steroid secretion and 11-beta-steroid hydroxylase activity after pituitary-adrenocortical probes in depression.
    Holsboer F
    Psychiatr Med; 1985; 3(1):65-78. PubMed ID: 2885897
    [No Abstract]   [Full Text] [Related]  

  • 2. Corticotropin-releasing hormone--a new tool to investigate hypothalamic-pituitary-adrenocortical physiology in psychiatric patients.
    Holsboer F
    Psychopharmacol Bull; 1986; 22(3):907-12. PubMed ID: 3025913
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I.
    Schmider J; Lammers CH; Gotthardt U; Dettling M; Holsboer F; Heuser IJ
    Biol Psychiatry; 1995 Dec; 38(12):797-802. PubMed ID: 8750037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence against changes in corticotroph CRF receptors in depressed patients.
    Young EA; Akil H; Haskett RF; Watson SJ
    Biol Psychiatry; 1995 Mar; 37(6):355-63. PubMed ID: 7772643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etomidate suppresses adrenocortical function by inhibition of 11 beta-hydroxylation.
    de Jong FH; Mallios C; Jansen C; Scheck PA; Lamberts SW
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1143-7. PubMed ID: 6092411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACTH and multisteroid responses to corticotropin-releasing factor in depressive illness: relationship to multisteroid responses after ACTH stimulation and dexamethasone suppression.
    Holsboer F; Müller OA; Doerr HG; Sippell WG; Stalla GK; Gerken A; Steiger A; Boll E; Benkert O
    Psychoneuroendocrinology; 1984; 9(2):147-60. PubMed ID: 6089243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metyrapone test and plasma hormone estimations (author's transl)].
    Ducassou D; Rashedi M; Brendel A; Gasparoux S
    Pathol Biol (Paris); 1977 Dec; 25(10):729-33. PubMed ID: 206869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACTH, cortisol, and corticosterone output after ovine corticotropin-releasing factor challenge during depression and after recovery.
    Holsboer F; Gerken A; Stalla GK; Müller OA
    Biol Psychiatry; 1985 Mar; 20(3):276-86. PubMed ID: 2983788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial 11 beta-hydroxylase activity suppression after dexamethasone in patients with major depression.
    Kathol RG; Gehris TL; Jaeckle R
    Acta Psychiatr Scand; 1988 Feb; 77(2):175-80. PubMed ID: 3259066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term kinetics of serum adrenal steroids and plasma ACTH after a single dose of metyrapone in man.
    Schöneshöfer M; Schefzig B; Arabin S
    J Endocrinol Invest; 1980; 3(3):229-36. PubMed ID: 6253555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of repeated human corticotropin-releasing hormone administration on dexamethasone-suppressed pituitary-adrenocortical activity in healthy subjects.
    Wiedemann K; Holsboer F
    Biol Psychiatry; 1997 Nov; 42(10):882-8. PubMed ID: 9359973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psychoneuroendocrinology].
    Holsboer F
    Internist (Berl); 1985 May; 26(5):302-8. PubMed ID: 2989208
    [No Abstract]   [Full Text] [Related]  

  • 13. The hypothalamic-pituitary-adrenal axis in depression.
    Meltzer HY; Lowy MT; Koenig JI
    Adv Biochem Psychopharmacol; 1987; 43():165-82. PubMed ID: 3035885
    [No Abstract]   [Full Text] [Related]  

  • 14. Toward an understanding of cortisol dysregulation in major depression: a review of studies of the dexamethasone suppression test and urinary free-cortisol.
    Reus VI
    Psychiatr Med; 1985; 3(1):1-21. PubMed ID: 3037609
    [No Abstract]   [Full Text] [Related]  

  • 15. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased evening activation of the hypothalamic-pituitary-adrenal axis in depressed patients.
    Young EA; Haskett RF; Grunhaus L; Pande A; Weinberg VM; Watson SJ; Akil H
    Arch Gen Psychiatry; 1994 Sep; 51(9):701-7. PubMed ID: 8080346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biologic diagnosis of depression by the TRH and dexamethasone tests].
    Chabrol H; Moron P
    Encephale; 1983; 9(1):1-22. PubMed ID: 6135596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable adrenocorticotropin-stimulated 11-beta-hydroxylase activity but loss of age-related changes in patients with hypercortisolemia.
    Kathol RG; Meller W; Jaeckle RS; Lopez JF
    Biol Psychiatry; 1987 Oct; 22(10):1243-52. PubMed ID: 2822155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?
    Ising M; Horstmann S; Kloiber S; Lucae S; Binder EB; Kern N; Künzel HE; Pfennig A; Uhr M; Holsboer F
    Biol Psychiatry; 2007 Jul; 62(1):47-54. PubMed ID: 17123470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of hyperadrenocorticism in dogs as compared to human diagnostic methods: a review.
    Thuróczy J; Balogh L; Huszenicza G; Jánoki GA; Kulcsár M
    Acta Vet Hung; 1998; 46(2):157-73. PubMed ID: 9704520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.